Free Trial

Crinetics Pharmaceuticals (CRNX) SEC Filings & 10K Form

Crinetics Pharmaceuticals logo
$29.88 +0.44 (+1.48%)
Closing price 07/3/2025 01:45 PM Eastern
Extended Trading
$30.20 +0.32 (+1.07%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Crinetics Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/26/2025
3:16 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:30 PM
Crinetics Pharmaceuticals (Filer)
Form DEF 14A
04/23/2025
3:33 PM
Crinetics Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:36 PM
Crinetics Pharmaceuticals (Filer)
Form ARS
04/07/2025
10:52 AM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
03/21/2025
5:31 PM
Crinetics Pharmaceuticals (Issuer)
Struthers Richard Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:32 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:33 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:34 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Schilke Tobin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
3:23 PM
Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:23 PM
Crinetics Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:10 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM
Crinetics Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
7:50 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
9:25 AM
Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:06 AM
Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/07/2025
9:23 AM
Crinetics Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
8:33 PM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/29/2025
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/29/2025
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/14/2025
4:02 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:34 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Kalofonos Isabel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:32 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
7:07 AM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
3:06 PM
Crinetics Pharmaceuticals (Subject)
Struthers Richard Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:55 PM
Crinetics Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:46 PM
Crinetics Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
Form SC 13G/A
11/12/2024
1:26 PM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Crinetics Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
10:20 AM
Crinetics Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
11:47 AM
Crinetics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:08 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:13 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
3:35 PM
Crinetics Pharmaceuticals (Filer)
Form 424B5
10/08/2024
4:01 PM
Crinetics Pharmaceuticals (Filer)
Form 424B5
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
10/07/2024
6:55 AM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:01 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:23 PM
Crinetics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:06 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
11:11 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:31 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
12:16 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
10:35 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
3:38 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:04 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
9:54 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
4:35 PM
Crinetics Pharmaceuticals (Issuer)
Knight Jeff E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:14 PM
Crinetics Pharmaceuticals (Issuer)
Wilson Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:38 PM
Crinetics Pharmaceuticals (Subject)
Knight Jeff E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:28 PM
Crinetics Pharmaceuticals (Subject)
Wilson Marc (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:30 PM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
9:28 AM
Betz Stephen F. (Reporting)
Crinetics Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
5:04 PM
Crinetics Pharmaceuticals (Issuer)
Hassard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:30 PM
Crinetics Pharmaceuticals (Issuer)
Pizzuti Dana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:10 PM
Crinetics Pharmaceuticals (Subject)
Hassard James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
12:07 PM
Crinetics Pharmaceuticals (Subject)
Pizzuti Dana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRNX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners